Yeku, Oladapo O.
Purdon, Terence J.
Koneru, Mythili
Spriggs, David
Brentjens, Renier J.
Article History
Received: 22 June 2017
Accepted: 16 August 2017
First Online: 5 September 2017
Competing Interests
: Renier J. Brentjens is a co-founder, stockholder and consultant for Juno Therapeutics Inc.